Nanotechnology-based drug delivery systems for treatment of oral cancer: a review

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin2013631113023335087
   PubMed Web of Science ®Google Scholar
• EpsteinJBZhangLRosinMAdvances in the diagnosis of oral premalignant and malignant lesionsJ Can Dent Assoc2002681061762112410942
   PubMedGoogle Scholar
• LlewellynCDJohnsonNWWarnakulasuriyaKARisk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern EnglandJ Oral Pathol Med200433952553215357672
   PubMed Web of Science ®Google Scholar
• ChitapanaruxILorvidhayaVSittitraiPOral cavity cancers at a young age: analysis of patient, tumor and treatment characteristics in Chiang Mai University HospitalOral Oncol2006421838816249113
   PubMed Web of Science ®Google Scholar
• BinnieWHRankinKVMackenzieICEtiology of oral squamous cell carcinomaJ Oral Pathol198312111296403682
   PubMedGoogle Scholar
• DouglassCWGammonMDReassessing the epidemiology of lip cancerOral Surg Oral Med Oral Pathol19845766316426377170
   PubMedGoogle Scholar
• de RosaIStaibanoSLo MuzioLPotentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosisJ Oral Pathol Med199928625225810426197
   PubMed Web of Science ®Google Scholar
• FriersonHFJrCooperPHPrognostic factors in squamous cell carcinoma of the lower lipHum Pathol19861743463543957335
   PubMed Web of Science ®Google Scholar
• NäsmanAAttnerPHammarstedtLIncidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?Int J Cancer2009125236236619330833
   PubMed Web of Science ®Google Scholar
• HafkampHCSpeelEJHaesevoetsAA subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8Int J Cancer2003107339440014506739
   PubMed Web of Science ®Google Scholar
• RaginCCTaioliESurvival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysisInt J Cancer200712181813182017546592
   PubMed Web of Science ®Google Scholar
• HuangBChenHFanMA postulated role for human papillomavirus (HPV) in the transformation and proliferation of oral squamous cell carcinoma (OSCC)Med Hypotheses20087051041104317910995
   PubMed Web of Science ®Google Scholar
• PetersenPEOral cancer prevention and control – the approach of the World Health OrganizationOral Oncol2009454–545446018804412
   PubMed Web of Science ®Google Scholar
• JonesDLRankinKVOral cancer and associated risk factorsCappelliDPMobleyCCPrevention in Clinical Oral Health CareSt Louis, MOMosby Elsevier20086877
   Google Scholar
• SuCCYangHFHuangSJLianIeBDistinctive features of oral cancer in Changhua County: high incidence, buccal mucosa preponderance, and a close relation to betel quid chewing habitJ Formos Med Assoc2007106322523317389167
   PubMed Web of Science ®Google Scholar
• ChenCJYouSLLinLHHsuWLYangYWCancer epidemiology and control in Taiwan: a brief reviewJpn J Cancer Res200232SupplS66S81
   Google Scholar
• KantolaSParikkaMJokinenKPrognostic factors in tongue cancer – relative importance of demographic, clinical and histopathological factorsBr J Cancer200083561461910944601
   PubMed Web of Science ®Google Scholar
• SankaranarayananRMasuyerESwaminathanRFerlayJWhelanSHead and neck cancer: a global perspective on epidemiology and prognosisAnticancer Res1998186B477947869891557
   PubMed Web of Science ®Google Scholar
• CarvalhoALMagrinJKowalskiLPSites of recurrence in oral and oropharyngeal cancers according to the treatment approachOral Dis20039311211812945592
   PubMed Web of Science ®Google Scholar
• ShahJPLydiattWTreatment of cancer of the head and neckCA Cancer J Clin19954563523687583907
   PubMed Web of Science ®Google Scholar
• OnofreMASpostoMRNavarroCMMottaMETurattiEAlmeidaRTPotentially malignant epithelial oral lesions: discrepancies between clinical and histological diagnosisOral Dis1997331481529467356
   PubMedGoogle Scholar
• BhalangKSuesuwanADhanuthaiKSannikornPLuangjarmekornLSwasdisonSThe application of acetic acid in the detection of oral squamous cell carcinomaOral Surg Oral Med Oral Pathol Oral Radiol Endod2008106337137618547833
   PubMed Web of Science ®Google Scholar
• EpsteinJBSilvermanSJrEpsteinJDLonkySABrideMAAnalysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blueOral Oncol200844653854417996486
   PubMed Web of Science ®Google Scholar
• Wilder-SmithPLeeKGuoSIn vivo diagnosis of oral dysplasia and malignancy using optical coherence tomography: preliminary studies in 50 patientsLasers Surg Med200941535335719533765
   PubMed Web of Science ®Google Scholar
• KochFPKaemmererPWBiesterfeldSKunkelMWagnerWEffectiveness of autofluorescence to identify suspicious oral lesions – a prospective, blinded clinical trialClin Oral Investig2010156975982
   PubMed Web of Science ®Google Scholar
• KochFPKunkelMBiesterfeldSWagnerWDiagnostic efficiency of differentiating small cancerous and precancerous lesions using mucosal brush smears of the oral cavity – a prospective and blinded studyClin Oral Investig2010155763769
   PubMed Web of Science ®Google Scholar
• ScullyCCancerOral and Maxillofacial Medicine: The Basis of Diagnosis and Treatment3rd edNew York, NYChurchill Livingstone Elsevier2013204217
   Google Scholar
• CsikarJAravaniAGodsonJDayMWilkinsonJIncidence of oral cancer among South Asians and those of other ethnic groups by sex in West Yorkshire and England, 2001–2006Br J Oral Maxillofac Surg2013511252922495403
   PubMed Web of Science ®Google Scholar
• WeinbergMAEstefanDJAssessing oral malignanciesAm Fam Physician20026571379138411996421
   PubMed Web of Science ®Google Scholar
• HomerJJGreenmanJStaffordNDAngiogenic cytokines in serum and plasma of patients with head and neck squamous cell carcimonaClin Otolaryngol Allied Sci200025657057611123175
   PubMedGoogle Scholar
• WeinbergRATumor suppressor genesScience19912545035113811461659741
   PubMed Web of Science ®Google Scholar
• MehrotraRVasstrandENIbrahimSORecent advances in understanding carcinogenicity of oral squamous cell carcinoma: from basic molecular biology to latest genomic and proteomic findingsCancer Genomics Proteomics200414283294
   PubMedGoogle Scholar
• KhanZBisenPSOncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancerBiochim Biophys Acta20131836112314523602834
   PubMed Web of Science ®Google Scholar
• VogelsteinBKinzlerKWThe multistep nature of cancerTrends Genet1993941381418516849
   PubMed Web of Science ®Google Scholar
• MehrotraRYadavSOral squamous cell carcinoma: etiology, pathogenesis and prognostic value of genomic alterationsIndian J Cancer2006432606616790942
   PubMedGoogle Scholar
• HollsteinMSidranskyDVogelsteinBHarrisCCp53 mutations in human cancersScience1991253501549531905840
   PubMed Web of Science ®Google Scholar
• BrennanJABoyleJOKochWMAssociation between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neckN Engl J Med1995332117127177854378
   PubMed Web of Science ®Google Scholar
• SchantzSPBasic science advances in head and neck oncology: the past decadeSemin Surg Oncol19951132722797638515
   PubMedGoogle Scholar
• CalifanoJAhrendtSAMeiningerGWestraWHKochWMSidranskyDDetection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patientsCancer Res19965624572057228971181
   PubMed Web of Science ®Google Scholar
• MiyoshiYTsukinokiKImaizumiTTelomerase activity in oral cancerOral Oncol199935328328910621849
   PubMed Web of Science ®Google Scholar
• BrachmanDGBeckettMGravesDHarafDVokesEWeichselbaumRRp53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell linesCancer Res19935316366736698339273
   PubMed Web of Science ®Google Scholar
• HaranoNOnoKHidakaKKaiANakanishiOInenagaKDifferences between orofacial inflammation and cancer painJ Dent Res201089661562020332329
   PubMed Web of Science ®Google Scholar
• PetersCMLindsayTHPomonisJDEndothelin and the tumorigenic component of bone cancer painNeuroscience200412641043105215207337
   PubMed Web of Science ®Google Scholar
• PickeringVJordanRCSchmidtBLElevated salivary endothelin levels in oral cancer patients – a pilot studyOral Oncol2007431374116757207
   PubMed Web of Science ®Google Scholar
• SchmidtBLPickeringVLiuSPeripheral endothelin A receptor antagonism attenuates carcinoma-induced painEur J Pain200711440641416807013
   PubMed Web of Science ®Google Scholar
• PickeringVJay GuptaRQuangPJordanRCSchmidtBLEffect of peripheral endothelin-1 concentration on carcinoma-induced pain in miceEur J Pain200812329330017664075
   PubMed Web of Science ®Google Scholar
• NybergPYlipalosaariMSorsaTSaloTTrypsins and their role in carcinoma growthExp Cel Res2006312812191228
   PubMed Web of Science ®Google Scholar
• LamDKSchmidtBLSerine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathwayPain2010149226327220189717
   PubMed Web of Science ®Google Scholar
• RussoASohUJTrejoJProteases display biased agonism at protease-activated receptors: location matters!Mol Interv200992879619401541
   PubMedGoogle Scholar
• AmadesiSCottrellGSDivinoLProtease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and miceJ Physiol2006575Pt 255557116793902
   PubMed Web of Science ®Google Scholar
• ZhengJTianXSunYLuDYangWpH-sensitive poly (glutamic acid) grafted mesoporous silica nanoparticles for drug deliveryInt J Pharm2013450129630323598077
   PubMedGoogle Scholar
• DavisBMLewinGRMendellLMJonesMEAlbersKMAltered expression of nerve growth factor in the skin of transgenic mice leads to changes in response to mechanical stimuliNeuroscience19935647897927506820
   PubMed Web of Science ®Google Scholar
• KleinRJingSQNanduriVO’RourkeEBarbacidMThe trk proto-oncogene encodes a receptor for nerve growth factorCell19916511891971849459
   PubMed Web of Science ®Google Scholar
• GlinskyGVIvanovaABVinnitskyVBArumäeUSiigurJNeumanTNerve growth factor may be the metastasis growth factorAnn N Y Acad Sci19874966566593496831
   PubMed Web of Science ®Google Scholar
• KolokythasACoxDPDekkerNSchmidtBLNerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: is there an association with perineural invasion?J Oral Maxillofac Surg20106861290129520363547
   PubMed Web of Science ®Google Scholar
• YeYDangDZhangJNerve growth factor links oral cancer progression, pain, and cachexiaMol Cancer Ther20111091667167621750223
   PubMed Web of Science ®Google Scholar
• OkadaYUenoHKatagiriMExperimental study of antiangiogenic gene therapy targeting VEGF in oral cancerOdontology2010981525920155508
   PubMed Web of Science ®Google Scholar
• RiedelFGötteKSchwalbJWirtzHBerglerWHörmannKSerum levels of vascular endothelial growth factor in patients with head and neck cancerEur Arch Otorhinolaryngol2000257633233610993554
   PubMed Web of Science ®Google Scholar
• ShangZJLiJRLiZBCirculating levels of vascular endothelial growth factor in patients with oral squamous cell carcinomaInt J Oral Maxillofac Surg200231549549812418564
   PubMed Web of Science ®Google Scholar
• MărgăritescuCPiriciDSimionescuCVEGF and VEGFRs expression in oral squamous cell carcinomaRom J Morphol Embryol200950452754819942948
   PubMed Web of Science ®Google Scholar
• SalimiMEsfahaniMHabibzadehNChange in nicotine-induced VEGF, PGE2 AND COX-2 expression following COX inhibition in human oral squamous cancerJ Environ Pathol Toxicol Oncol201231434935623394447
   PubMed Web of Science ®Google Scholar
• ColottaFAllavenaPSicaAGarlandaCMantovaniACancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis20093071073108119468060
   PubMed Web of Science ®Google Scholar
• Del PreteAAllavenaPSantoroGFumaruloRCorsiMMMantovaniAMolecular pathways in cancer-related inflammationBiochem Med (Zagreb)201121326427522420240
   PubMed Web of Science ®Google Scholar
• KampDWShacterEWeitzmanSAChronic inflammation and cancer: the role of the mitochondriaOncology (Williston Park)201125540041041321710835
   PubMed Web of Science ®Google Scholar
• MignognaMDFedeleSLo RussoLLo MuzioLBucciEImmune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence?Oral Oncol200440212013014693234
   PubMed Web of Science ®Google Scholar
• LiTJCuiJCOX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinomaAsian Pac J Trop Biomed201368640643
   Web of Science ®Google Scholar
• GeorgakopoulouEAAchtariMDAchtarisMFoukasPGKotsinasAOral lichen planus as a preneoplastic inflammatory modelJ Biomed Biotechnol2012201275962622675259
   PubMedGoogle Scholar
• PontesHAPontesFSFonsecaFPNuclear factor kappa B and cyclooxygenase-2 immunoexpression in oral dysplasia and oral squamous cell carcinomaAnn Diagn Pathol2013171455022818026
   PubMed Web of Science ®Google Scholar
• MauroALipariLLeoneAExpression of cyclooxygenase-1 and cyclooxygenase-2 in normal and pathological human oral mucosaFolia Histochem Cytobiol201048455556321478098
   PubMed Web of Science ®Google Scholar
• Goulart FilhoJANonakaCFda Costa MiguelMCde Almeida FreitasRGalvãoHCImmunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinomaAm J Otolaryngol2009302899419239949
   PubMed Web of Science ®Google Scholar
• ImpolaUUittoVJHietanenJDifferential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancerJ Pathol20042021142214694517
   PubMed Web of Science ®Google Scholar
• VuTHWerbZMatrix metalloproteinases: effectors of development and normal physiologyGenes Dev200014172123213310970876
   PubMed Web of Science ®Google Scholar
• WernerJARathckeIOMandicRThe role of matrix metalloproteinases in squamous cell carcinomas of the head and neckClin Exp Metastasis200219427528212090467
   PubMed Web of Science ®Google Scholar
• EgebladMWerbZNew functions for the matrix metalloproteinases in cancer progressionCancer20022316117411990853
   PubMed Web of Science ®Google Scholar
• VairaktarisESerefoglouZYapijakisCHigh gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancerAnticancer Res2007274B2493249817695544
   PubMed Web of Science ®Google Scholar
• KarinMNuclear factor-kappa B in cancer development and progressionNature2006441709243143616724054
   PubMed Web of Science ®Google Scholar
• BindhuOSRamadasKSebastianPPillaiMRHigh expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinomaHead Neck2006281091692516823875
   PubMed Web of Science ®Google Scholar
• RichmondANf-kappa B, chemokine gene transcription and tumour growthNat Rev Immunol20022966467412209135
   PubMed Web of Science ®Google Scholar
• de VisscherJGBehandeling en prognose van het mondholtecarcinoom [Treatment and prognosis of oral cancer]Ned Tijdschr Tandheelkd20081154192198 Dutch18512517
   PubMedGoogle Scholar
• AdelsteinDJLiYAdamsGLAn intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancerJ Clin Oncol2003211929812506176
   PubMed Web of Science ®Google Scholar
• BachaudJMCohen-JonathanEAlzieuCDavidJMSerranoEDaly-SchveitzerNCombined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trialInt J Radiat Oncol Biol Phys199636599910048985019
   PubMed Web of Science ®Google Scholar
• BaselgaJTrigoJMBourhisJPhase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neckJ Clin Oncol200523245568557716009950
   PubMed Web of Science ®Google Scholar
• BonnerJAHarariPMGiraltJRadiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckN Engl J Med2006354656757816467544
   PubMed Web of Science ®Google Scholar
• CatimelGVerweijJMattijssenVDocetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupAnn Oncol1994565335377918125
   PubMed Web of Science ®Google Scholar
• ClavelMVermorkenJBCognettiFRandomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative GroupAnn Oncol1994565215267522527
   PubMed Web of Science ®Google Scholar
• HaddadRSonisSPosnerMRandomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancerCancer2009115194514452319634161
   PubMed Web of Science ®Google Scholar
• VermorkenJBMesiaRRiveraFPlatinum-based chemotherapy plus cetuximab in head and neck cancerN Engl J Med2008359111116112718784101
   PubMed Web of Science ®Google Scholar
• VermorkenJBRemenarEvan HerpenCCisplatin, fluorouracil, and docetaxel in unresectable head and neck cancerN Engl J Med2007357171695170417960012
   PubMed Web of Science ®Google Scholar
• VermorkenJBTrigoJHittROpen-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapyJ Clin Oncol200725162171217717538161
   PubMed Web of Science ®Google Scholar
• TerwogtJMSchellensJHHuininkWWBeijnenJHClinical pharmacology of anticancer agents in relation to formulations and administration routesCancer Treat Rev19992528310110395834
   PubMed Web of Science ®Google Scholar
• AgüerosMRuiz-GatónLVauthierCCombined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxelEur J Pharm Sci200938440541319765652
   PubMed Web of Science ®Google Scholar
• DevalapallyHChakilamAAmijiMMRole of nanotechnology in pharmaceutical product developmentJ Pharm Sci200796102547256517688284
   PubMed Web of Science ®Google Scholar
• KruijtzerCMBeijnenJHSchellensJHImprovement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overviewOncologist20027651653012490739
   PubMed Web of Science ®Google Scholar
• KumarGPRajeshwarraoPNonionic surfactant vesicular systems for effective drug delivery – an overviewActa Pharm Sin B201114208219
   Web of Science ®Google Scholar
• ManmodeASSakarkarDMMahajanNMNanoparticles-tremendous therapeutic potential: a reviewInternational Journal of Pharm Tech Research20091410201027
   Google Scholar
• NehaBGaneshBPreetiKDrug delivery to the brain using polymeric nanoparticles: a reviewInternational Journal of Pharmaceutical and Life Sciences201323107132
   Google Scholar
• ChoKWangXNieSChenZGShinDMTherapeutic nanoparticles for drug delivery in cancerClin Cancer Res20081451310131618316549
   PubMed Web of Science ®Google Scholar
• CouvreurPNanoparticles in drug delivery: past, present and futureAdv Drug Deliv Rev2013651212322580334
   PubMed Web of Science ®Google Scholar
• KamimuraMFurukawaTAkiyamaS-INagasakiYEnhanced intracellular drug delivery of pH-sensitive doxorubicin/poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) nanoparticles in multi-drug resistant human epidermoid KB carcinoma cellsBiomater Sci201314361367
   PubMed Web of Science ®Google Scholar
• DuFMengHXuKCPT loaded nanoparticles based on beta-cyclodextrin-grafted poly(ethylene glycol)/poly(L-glutamic acid) diblock copolymer and their inclusion complexes with CPTColloids Surf B Biointerfaces201411323023624096159
   PubMed Web of Science ®Google Scholar
• RavikumaraNRTiyaboonchaiWMadhusudhanBFabrication and characterization of genistein encapsulated poly (D, L) lactic acid nanoparticles for pharmaceutical applicationCurr Nanosci201392293302
   Web of Science ®Google Scholar
• PanyamJZhouWZPrabhaSSahooSKLabhasetwarVRapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryFASEB J200216101217122612153989
   PubMed Web of Science ®Google Scholar
• RenFChenRWangYSunYJiangYLiGPaclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancerPharm Res201128489790621184150
   PubMed Web of Science ®Google Scholar
• KooHMinKHLeeSCEnhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel deliveryJ Control Release2013172382383124035978
   PubMed Web of Science ®Google Scholar
• LeeKYMooneyDJAlginate: properties and biomedical applicationsProg Polym Sci201237110612622125349
   PubMed Web of Science ®Google Scholar
• DasRKKasojuNBoraUEncapsulation of curcumin in alginatechitosan-pluronic composite nanoparticles for delivery to cancer cellsNanomedicine20106115316019616123
   PubMed Web of Science ®Google Scholar
• WangHZhaoPLiangXFolate-PEG coated cationic modified chitosan – cholesterol liposomes for tumor-targeted drug deliveryBiomaterials201031144129413820163853
   PubMed Web of Science ®Google Scholar
• MohanrajVJChenYNanoparticles – a reviewTropical Journal of Pharmaceutical Research200651561573
   Google Scholar
• FanWYanWXuZNiHFormation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation techniqueColloids Surf B Biointerfaces201290212722014934
   PubMed Web of Science ®Google Scholar
• MakadiaHKSiegelSJPoly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrierPolymers (Basel)2011331377139722577513
   PubMed Web of Science ®Google Scholar
• DhandaDSTyagiPMirvishSSKompellaUBSupercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single doseJ Control Release2013168323925023562638
   PubMed Web of Science ®Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562720616808
   PubMed Web of Science ®Google Scholar
• ChuKSSchorzmanANFinnissMCNanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacyBiomaterials201334338424842923899444
   PubMed Web of Science ®Google Scholar
• MahapatroASinghDKBiodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccinesJ Nanobiotechnology2011915522123084
   PubMed Web of Science ®Google Scholar
• Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Deliv Rev201264206212
   Web of Science ®Google Scholar
• BrewerEColemanJLowmanAEmerging technologies of polymeric nanoparticles in cancer drug deliveryJ Nanomater20112011408675
   Web of Science ®Google Scholar
• DamascelliBPatelliGLLanocitaRA novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findingsAJR Am J Roentgenol2003181125326012818869
   PubMed Web of Science ®Google Scholar
• SulfikkaraliNKrishnakumarNManoharanSNirmalRMChemopreventive efficacy of naringenin-loaded nanoparticles in 7,12-dimethylbenz(a)anthracene induced experimental oral carcinogenesisPathol Oncol Res201319228729623233294
   PubMed Web of Science ®Google Scholar
• YuDWangAHuangHChenYPEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinomaNanomedicine (Lond)20083681382119025455
   PubMed Web of Science ®Google Scholar
• EndoKUenoTKondoSTumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinomaCancer Sci2013104336937423216802
   PubMed Web of Science ®Google Scholar
• LiPZhouGZhuXPhotodynamic therapy with hyperbranched poly(ether-ester) chlorin(e6) nanoparticles on human tongue carcinoma CAL-27 cellsPhotodiagnosis Photodyn Ther201291768222369732
   PubMed Web of Science ®Google Scholar
• Dos SantosFKOyafusoMHKiillCPDaflon-GremiaoMPChorilliMNanotechnology-based drug delivery systems for treatment of hyperproliferative skin diseases – a reviewCurr Nanosci201391159167
   Web of Science ®Google Scholar
• Ribeiro de SouzaALKiillCPdos SantosFKNanotechnology-based drug delivery systems for dermatomycosis treatmentCurr Nanosci201284512519
   Web of Science ®Google Scholar
• ParveenSMisraRSahooSKNanoparticles: a boon to drug delivery, therapeutics, diagnostics and imagingNanomedicine20128214716621703993
   PubMed Web of Science ®Google Scholar
• SoutoEBDoktorovováSChapter 6 – solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug deliveryMethods Enzymol200946410512919903552
   PubMed Web of Science ®Google Scholar
• WissingSKayserOMüllerRSolid lipid nanoparticles for parenteral drug deliveryAdv Drug Deliv Rev20045691257127215109768
   PubMed Web of Science ®Google Scholar
• MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev200147216519611311991
   PubMed Web of Science ®Google Scholar
• MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
   PubMed Web of Science ®Google Scholar
• PatelMSoutoEBSinghKKAdvances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticlesExpert Opin Drug Deliv201310788990523550609
   PubMed Web of Science ®Google Scholar
• ShiSJZhongZRLiuJZhangZRSunXGongTSolid lipid nanoparticles loaded with anti-microRNA oligonucleotides (AMOs) for suppression of microRNA-21 functions in human lung cancer cellsPharm Res20122919710921732152
   PubMed Web of Science ®Google Scholar
• KakkarVSinghSSinglaDKaurIPExploring solid lipid nanoparticles to enhance the oral bioavailability of curcuminMol Nutr Food Res201155349550320938993
   PubMed Web of Science ®Google Scholar
• HolpuchASHummelGJTongMNanoparticles for local drug delivery to the oral mucosa: proof of principle studiesPharm Res20102771224123620354767
   PubMed Web of Science ®Google Scholar
• BattagliaLGallarateMLipid nanoparticles: state of the art, new preparation methods and challenges in drug deliveryExpert Opin Drug Deliv20129549750822439808
   PubMed Web of Science ®Google Scholar
• FangJYFangCLLiuCHSuYHLipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)Eur J Pharm Biopharm200870263364018577447
   PubMed Web of Science ®Google Scholar
• LinYKHuangZRZhuoRZFangJYCombination of calcipotriol and methotrexate in nanostructured lipid carriers for topical deliveryInt J Nanomedicine2010511712820309398
   PubMed Web of Science ®Google Scholar
• KovacevicASavicSVuletaGMüllerRKeckCPolyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structureInt J Pharm20114061–216317221219990
   PubMedGoogle Scholar
• AdityaNShimMLeeILeeYImMHKoSCurcumin and genistein coloaded nanostructured lipid carriers: In vitro digestion and antiprostate cancer activityJ Agric Food Chem20136181878188323362941
   PubMed Web of Science ®Google Scholar
• ZlotogorskiADayanADayanDChaushuGSaloTVeredMNutraceuticals as new treatment approaches for oral cancer – I: curcuminOral Oncol201349318719123116961
   PubMed Web of Science ®Google Scholar
• ChinsriwongkulAChareanputtakhunPNgawhirunpatTNanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drugAAPS Pharm Sci Tech2012131150158
   PubMed Web of Science ®Google Scholar
• WangJDaiYHuangYAll-trans retinoic acid restores gap junctional intercellular communication between oral cancer cells with upregulation of Cx32 and Cx43 expressions in vitroMed Oral Patol Oral Cir Bucal2013184e569e57723524428
   PubMed Web of Science ®Google Scholar
• LiuSlZhongSSYeDXChenWTZhangZYDengJRepression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinomaJ Oral Pathol Med2013421076176823651229
   PubMed Web of Science ®Google Scholar
• LiuDLiuZWangLZhangCZhangNNanostructured lipid carriers as novel carrier for parenteral delivery of docetaxelColloids Surf B Biointerfaces201185226226921435845
   PubMed Web of Science ®Google Scholar
• IidaSShimadaJSakagamiHCytotoxicity induced by docetaxel in human oral squamous cell carcinoma cell linesIn Vivo201327332133223606687
   PubMed Web of Science ®Google Scholar
• ZhangTChenJZhangYShenQPanWCharacterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposideJ Pharm Sci2011433174179
   Web of Science ®Google Scholar
• MishimaKInoueKHayashiYOverexpression of extracellular-signal regulated kinases on oral squamous cell carcinomaOral Oncol200238546847412110341
   PubMed Web of Science ®Google Scholar
• LiuLTangYGaoCCharacterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriersColloids Surf B Biointerfaces201411512513124333909
   PubMed Web of Science ®Google Scholar
• KangBMackeyMAEl-SayedMANuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosisJ Am Chem Soc201013251517151920085324
   PubMed Web of Science ®Google Scholar
• WangFWangYCDouSXiongMHSunTMWangJDoxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cellsACS Nano2011553679369221462992
   PubMed Web of Science ®Google Scholar
• El-SayedIHHuangXEl-SayedMASurface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancerNano Lett20055582983415884879
   PubMed Web of Science ®Google Scholar
• KahJCKhoKWLeeCGEarly diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticlesInt J Nanomedicine20072478579818203445
   PubMed Web of Science ®Google Scholar
• AfifiMMEl SheikhSMAbdelsalamMMTherapeutic efficacy of plasmonic photothermal nanoparticles in hamster buccal pouch carcinomaOral Surg Oral Med Oral Pathol Oral Radiol2013115674375123454046
   PubMed Web of Science ®Google Scholar
• MezeiMGulasekharamVLiposomes – a selective drug delivery system for the topical route of administration. Lotion dosage formLife Sci19802618147314776893068
   PubMed Web of Science ®Google Scholar
• LianTHoRJTrends and developments in liposome drug delivery systemsJ Pharm Sci200190666768011357170
   PubMed Web of Science ®Google Scholar
• AllenTMCullisPRDrug delivery systems: entering the mainstreamScience200430356651818182215031496
   PubMed Web of Science ®Google Scholar
• Pedroso de LimaMCSimõesSPiresPFanecaHDüzgüneşNCationic lipid–DNA complexes in gene delivery: from biophysics to biological applicationsAdv Drug Deliv Rev200147227729411311996
   PubMed Web of Science ®Google Scholar
• KonopkaKFallahBMonzon-DullerJOverlidNDüzgünesNSerum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: application to HSV-tk/ganciclovir-mediated cytotoxicityCell Mol Biol Lett200510345547016217556
   PubMed Web of Science ®Google Scholar
• Figueiró LongoJPMuehlmannLAVellosoNVEffects of photodynamic therapy mediated by liposomal aluminum-phthalocyanine chloride on chemically induced tongue tumorsChemotherapy20121103
   Google Scholar
• VellosoNVMuehlmannLALongoJPFAluminum-phthalocyanine chloride-based photodynamic therapy inhibits PI3K/Akt/Mtor pathway in oral squamous cell carcinoma cells in vitroChemotherapy20121107
   Google Scholar
• BahramMHoseinzadehFFarhadiKSaadatMNajafi-MoghaddamPAfkhamiASynthesis of gold nanoparticles using pH-sensitive hydrogel and its application for colorimetric determination of acetaminophen, ascorbic acid and folic acidColloids Surf A Physicochem Eng Asp2014441517524
   Web of Science ®Google Scholar
• GiriTKThakurAAlexanderAAjazuddinBadwaikHTripathiDKModified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applicationsActa Pharm Sin B201225439449
   Google Scholar
• Ruel-GariépyEShiveMBicharaAA thermosensitive chitosan-based hydrogel for the local delivery of paclitaxelEur J Pharm Biopharm2004571536314729080
   PubMed Web of Science ®Google Scholar
• ObaraKIshiharaMOzekiYControlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in miceJ Control Release20051101798916289419
   PubMed Web of Science ®Google Scholar
• KonishiMTabataYKariyaMIn vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogelJ Control Release200392330131314568411
   PubMed Web of Science ®Google Scholar
• GurskiLAJhaAKZhangCJiaXFarach-CarsonMCHyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cellsBiomaterials200930306076608519695694
   PubMed Web of Science ®Google Scholar
• GaoYRenFDingBA thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of docetaxelJ Drug Target201119751652720883085
   PubMed Web of Science ®Google Scholar
• HaoTLiZQiaoMFanQZhangNChenDPreparation of docetaxel hydrogels for subcutaneous injection and their release profile in vitroChinese Pharmaceutical Journal20092415 Chinese
   Google Scholar
• ShakerDSGhorabMKKlingnerATeiamaMSIn-situ injectable thermosensitive gel based on poloxamer as a new carrier for tamoxifen citrateInt J Pharm Pharm Sci20135Suppl 4429437
   Google Scholar
• KonishiMTabataYKariyaMIn vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogelJ Control Release2005103171915710496
   PubMed Web of Science ®Google Scholar
• DeurlooMMKopWvan TellingenOBartelinkHBeggAIntratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distributionCancer Chemother Pharmacol19912753473531998994
   PubMed Web of Science ®Google Scholar
• TauroJRGemeinhartRAExtracellular protease activation of chemotherapeutics from hydrogel matrices: a new paradigm for local chemotherapyMol Pharm20052543543816196497
   PubMedGoogle Scholar
• CasolaroMCiniRDel BelloBFerraliMMaellaroECisplatin/hydrogel complex in cancer therapyBiomacromolecules200910494494919254026
   PubMed Web of Science ®Google Scholar
• FangLWangHZhouLYuDFOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cellsToxicol Appl Pharmacol2011251181521092744
   PubMed Web of Science ®Google Scholar
• MouraMJGilMHFigueiredoMMDelivery of cisplatin from thermosensitive co-cross-linked chitosan hydrogelsEur Polym J201349925042510
   Web of Science ®Google Scholar
• Salamat-MillerNChittchangMJohnstonTPThe use of mucoadhesive polymers in buccal drug deliveryAdv Drug Deliv Rev200557111666169116183164
   PubMed Web of Science ®Google Scholar
• EmotoSYamaguchiHKameiTIntraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancerSurg Today201444591992623887848
   PubMed Web of Science ®Google Scholar
• LiJGongCFengXBiodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenograftsPloS One201274e3386022529899
   PubMed Web of Science ®Google Scholar
• FormarizTPUrbanMCCda Silva JúniorAAGremiãoMPDde OliveiraAGMicroemulsões e fases líquidas cristalinas como sistemas de liberação de fármacos [Microemulsion and liquid crystals as drug delivery systems]Revista Brasileira de Ciências Farmacêuticas200541301313 Portuguese
   Google Scholar
• ChorilliMPrestesPSRigonRBLeonardiGRChiavacciLAScarpaMVDesenvolvimento de sistemas líquido-cristalinos empregando silicone fluido de co-polímero glicol e poliéter funcional siloxano [Development of liquid-crystalline systems using silicon glycol copolymer and polyether functional siloxane]Quim Nova20093210361040 Portuguese
   Web of Science ®Google Scholar
• PrestesPSChorilliMChiavacciLAScarpaMVLeonardiGRPhysicochemical characterization and rheological behavior evaluation of the liquid crystalline mesophases developed with different siliconesJ Dispers Sci Technol2009311117123
   Web of Science ®Google Scholar
• ManaiaEBKaminskiRCKSoaresCPLiquid crystalline formulations containing modified surface TiO2 nanoparticles obtained by sol–gel processJ Solgel Sci Technol2012632251257
   Web of Science ®Google Scholar
• de Castro SantanaRFasolinLHda CunhaRLEffects of a cosurfactant on the shear-dependent structures of systems composed of biocompatible ingredientsColloids Surf A Physicochem Eng Asp20123985463
   Web of Science ®Google Scholar
• EzrahiSAserinAGartiNAggregation behavior in one-phase (Winsor IV) microemulsion systemsKumarPMittalKLHandbook of Microemulsion Science and TechnologyNew York, NYMarcel Dekker, Inc1999185246
   Google Scholar
• HosmerJMShinSHNornooAZhengHLopesLBInfluence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxelJ Pharm Sci201110041444145520957759
   PubMed Web of Science ®Google Scholar
• MyoungHHongSDKimYYHongSPKimMJEvaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinomaCancer Lett2001163219120011165754
   PubMed Web of Science ®Google Scholar
• KioiMShimamuraTNakashimaHIL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinomaInt J Cancer200912461440144819065664
   PubMed Web of Science ®Google Scholar
• EckardtASinikovicBHofeleCBremerMReuterCPreoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trialOncology2008733–419820318424883
   PubMed Web of Science ®Google Scholar
• CheungMCPantanowitzLDezubeBJAIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapyOncologist200510641242615967835
   PubMed Web of Science ®Google Scholar
• FergusonTWilckenNVaggRGhersiDNowakATaxanes for adjuvant treatment of early breast cancerCochrane Database Syst Rev20074CD00442117943815
   PubMed Web of Science ®Google Scholar
• RizwanSAssmusDBoehnkeAPreparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccinesEur J Pharm Biopharm2011791152221237267
   PubMed Web of Science ®Google Scholar
• ZengNHuQLiuZPreparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailabilityInt J Pharm20124241–2586622240390
   PubMedGoogle Scholar
• MartinsMRFMVeigaFPromotores de permeação para a liberação transdérmica de fármacos: uma nova aplicação para as ciclodextrinas [Permeation enhancers in transdermal drug delivery systems: a new application of cyclodextrins]Revista Brasileira de Ciências Farmacêuticas20023813354 Portuguese
   Google Scholar
• LiSPurdyWCCyclodextrins and their applications in analytical chemistryChem Rev199292614571470
   Web of Science ®Google Scholar
• ZhangJMaPXCyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspectiveAdv Drug Deliv Rev20136591215123323673149
   PubMed Web of Science ®Google Scholar
• ConcheiroAAlvarez-LorenzoCChemically cross-linked and grafted cyclodextrin hydrogels: from nanostructures to drug-eluting medical devicesAdv Drug Deliv Rev20136591188120323631979
   PubMed Web of Science ®Google Scholar
• SzejtliJOsaTComprehensive Supramolecular Chemistry. Vol 3: CyclodextrinsOxfordElsevier Science Ltd1996
   Google Scholar
  SzejtliJIntroduction and general overview of cyclodextrin chemistryChem Rev19969851743175411848947
   PubMed Web of Science ®Google Scholar
• VeigaFJBComplexos de Inclusão com Ciclodextrinas Hidrófilas: Caracterização Físico-Química e Biofarmacêutica[Inclusion complexes with hydrophilic cyclodextrins: Physico-chemical and biopharmaceutical characterization] [doctoral thesis]CoimbraUniversity of Coimbra1996 Portuguese
   Google Scholar
• SallasFDarcyRAmphiphilic cyclodextrins – advances in synthesis and supramolecular chemistryEuropean J Org Chem20086957969
   Web of Science ®Google Scholar
• HirayamaFUekamaKCyclodextrin-based controlled drug release systemAdv Drug Deliv Rev199936112514110837712
   PubMed Web of Science ®Google Scholar
• RamineniSKCunninghamLLDziublaTDPuleoDADevelopment of imiquimod-loaded mucoadhesive films for oral dysplasiaJ Pharm Sci2013102259360323192692
   PubMed Web of Science ®Google Scholar
• JingJSzarpak-JankowskaAGuillotRPignot-PaintrandIPicartCAuzély-VeltyRCyclodextrin/paclitaxel complex in biodegradable capsules for breast cancer treatmentChem Mater2013251938673873
   Web of Science ®Google Scholar
• HeHChenSZhouJCyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxelBiomaterials201334215344535823591391
   PubMed Web of Science ®Google Scholar
• EiferACThaxtonCSNanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case studyHurstSJBiomedical Nanotechnology: Methods and ProtocolsNew YorkHumana Press2011235338
   Google Scholar
• YangKWenYWangCClinical application of anticancer nanoparticles targeting metastasis foci of cervical lymph nodes in patients with oral carcinomaHua Xi Kou Qiang Yi Xue Za Zhi2003216447450 Chinese14732978
   PubMedGoogle Scholar
• HullLCFarrellDGrodzinskiPHighlights of recent developments and trends in cancer nanotechnology research-View from NCI Alliance for Nanotechnology in CancerBiotechnol Adv Epub1282013
   PubMed Web of Science ®Google Scholar